Experimental Study of Anxnatase Inhibitor Lentaron on Endometrial Carcinoma Cell Line

张薏,魏丽惠,王建六,李小平,富琪,屠铮,虞有智

DOI: https://doi.org/10.3969/j.issn.1672-1861.2001.05.013

2001-01-01

Abstract:Objective To study the proliferation of cells and transcription levels in the presence or absence of testosterone (T) by lentaron, a steroidal aromatase inhibitor, on endometrial carcinoma cell lines HEC - 1A. Methods According to agent added in the culture, four groups were divided, L group with 10-6 M lentaron and 0.1% DMSO (V/V) , T group with 10-6M testosterone and 0.1% DMSO (V/V), LT group with 10-6M lentaron, 10-6M testosterone and 0.1% DMSO (V/V), while the control group with 0.1% DMSO (V/V), and the HEC-1A, MCF-7, and Hela cells were cultured into these groups respectively.The growth of cells, cell cycles, apoptotic index and the level of the aromatase cytochrome P450 (P450arom) mR-NA were measured by MTT colorimetric assay, flow cytometry (FCM) and RT- PCR respectively. Results ①Proliferation of cells were obtained in the three cultured cell lines when T was added in 10-6M, however in HEC - 1A and Hela cell lines, the rise by T could be supressed markedly by the addition of lentaron, but no significant suppression was found in MCF - 7. By FCM, a rise of apoptotic index was shown in HEC -1A cells when lentaron was added in the presence of T.②When T was added, the levels of aromatase mRNA were all incereased in the three kinds of cell lines, but lentaron could markedly suppress the rise. Conclusions The above finding illustrated that lentaron could suppress the promotion of the rise of aromatase by androgen in endometrial carcinoma cells which may be related with the enhancement of apotosis.